Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...

Alcon and RxSight partner to develop light-adjustable presbyopia-correcting IOLs, including $60M upfront and milestone payments.

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

Alcon ALC recently announced the launch of the Clareon Family of Intraocular Lenses (IOLs) in India. The company’s most advanced platform to date builds on its long legacy of IOL innovation and is the ...

TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2 TruPlus demonstrates higher distance image quality across ...

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

HUNTINGTON — The Huntington Alcon IOL Manufacturing Division of Alcon Laboratories has successfully met the criteria to achieve a national Well Workplace designation by the Wellness Councils of ...

Basel, Switzerland, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSert™ Pre-loaded ...

Please provide your email address to receive an email when new articles are posted on . The lens will launch in the U.S. in May. It is designed to provide more uninterrupted light distribution and ...

“We are proud to offer our latest IOL technology in the U.S. and other countries across the globe. At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to ...